Illinois

Showing 1-10 of 17 grants

Title	Institution	Researcher	Program	Duration	Total Award Amount
Utilizing AI to Establish an Inception Cohort of Persons Living with Type 1 Diabetes Mellitus to Study Trajectories of Glycemic Variability and Related Risk Factors and Their Influence on Subsequent Risk of Cardiovascular Disease	Northwestern University	Sara Hassani	Improving Lives	01-April-2026 to 31-March-2029	$1.014.920,00
Regenerable Reagentless Sensors for Continuous Monitoring of Insulin	Northwestern University	Shana Kelley	Improving Lives	01-March-2026 to 29-February-2028	$348.937,89
Interferons and the Integrated Stress Response: Converging Pathways in β Cell Dysfunction in Type 1 Diabetes	The University of Chicago	Charanya Muralidharan	Cures	01-March-2026 to 28-February-2029	$285.000,00
Programming Pancreatic Cell Replacement Therapeutics Using Cellgorithm Technology	Syntax Bio, Inc	Ryan Clarke	Cures	15-November-2025 to 14-November-2027	$856.250,00
Safety and efficacy assessment of Tegoprubart and calcineurin inhibitors- free immunosuppression therapy for pancreatic islet transplantation in patients with t1DM and chronic kidney disease.	The University of Chicago	Piotr Witkowski	Cures	01-September-2025 to 31-August-2029	$8.500.000,00
Dissecting HLA Mechanisms in T1D, SLE, and MS Through High-Throughput Self-Antigen Profiling	The University of Chicago	Aly Khan	Cures	01-September-2025 to 31-August-2026	$150.000,00
PLGA nanoparticle treatment-induced antigen-specific CD4+ regulatory T cell control of effector CD8+ T cell responses in a model of type 1 diabetes	Northwestern University	Stephen Miller	Cures	01-September-2025 to 31-August-2028	$659.990,00
A pilot study assessing the safety of using a monoclonal antibody against CD40 ligand to achieve a calcineurin inhibitor-free immunosuppression regimen in patients with type 1 diabetes mellitus (T1D) and problematic hypoglycemia undergoing islet cell transplantation	The University of Chicago	Piotr Witkowski	Cures	01-February-2025 to 31-January-2027	$1.500.000,00
Development of β-Cell Targeted Lipid Nanoparticle Therapeutics	The University of Chicago	Jacob Ryan Enriquez	Cures	01-March-2025 to 29-February-2028	$247.790,00
A hybrid effectiveness implementation trial of an intervention to reduce diabetes-specific emotional distress.	Ann & Robert H. Lurie Children’s Hospital of Chicago	Jill Weissberg-Benchell	Improving Lives	01-September-2024 to 31-August-2029	$1.936.551,00